The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Lombart Instrument sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Lohmann & Rauscher International GmbH & Co KG (Lohmann & Rauscher)) is a healthcare solutions provider. The company’s primary activities include the development of products and services in collaboration with users, scientific networks and other partners, with a focus on meeting high standards. Its product portfolio includes wound care, negative pressure therapy, compression, support and retention products, supports and orthoses, plaster room and operating room products, disinfection products, and dermatology solutions, among others. The company caters to the needs of healthcare professionals and patients across various sectors of the healthcare industry. Lohmann & Rauscher is headquartered in Neuwied, Rhineland-pfalz, Germany. Key subsidiaries of Lombart Instrument include Enhanced Medical Services and Innova Medical Ophthalmics.
The key metrics of Lombart Instrument related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Lombart Instrument is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Lombart Instrument.
For a detailed understanding of the performance of Lombart Instrument, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
